Cargando…

A Molecular Modeling Investigation of the Therapeutic Potential of Marine Compounds as DPP-4 Inhibitors

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by elevated levels of blood glucose due to insulin resistance or insulin-secretion defects. The development of diabetes is mainly attributed to the interaction of several complex pathogenic, genetic, environmental and meta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antony, Priya, Baby, Bincy, Aleissaee, Hamda Mohammed, Vijayan, Ranjit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788368/ https://www.ncbi.nlm.nih.gov/pubmed/36547924 http://dx.doi.org/10.3390/md20120777

Ejemplares similares

From Desert to Medicine: A Review of Camel Genomics and Therapeutic Products
por: Ali, Amanat, et al.
Publicado: (2019)

Structural insights into the polypharmacological activity of quercetin on serine/threonine kinases
por: Baby, Bincy, et al.
Publicado: (2016)

Molecular insights into the interaction of hemorphin and its targets
por: Ali, Amanat, et al.
Publicado: (2019)

Acetogenins from Annona muricata as potential inhibitors of antiapoptotic proteins: a molecular modeling study
por: Antony, Priya, et al.
Publicado: (2016)

Identification of Novel Aldose Reductase Inhibitors from Spices: A Molecular Docking and Simulation Study
por: Antony, Priya, et al.
Publicado: (2015)

Carnosol Is a Novel Inhibitor of p300 Acetyltransferase in Breast Cancer
por: Alsamri, Halima, et al.
Publicado: (2021)

Bioactive Peptides as Potential Nutraceuticals for Diabetes Therapy: A Comprehensive Review
por: Antony, Priya, et al.
Publicado: (2021)

Positive Modulation of Angiotensin II Type 1 Receptor–Mediated Signaling by LVV–Hemorphin-7
por: Ali, Amanat, et al.
Publicado: (2019)

Molecular Dynamics Simulation Study of the Interaction between Human Angiotensin Converting Enzyme 2 and Spike Protein Receptor Binding Domain of the SARS-CoV-2 B.1.617 Variant
por: Antony, Priya, et al.
Publicado: (2021)

Draft Genome Sequence of Bacillus cereus Strain UAEU-H3K6M1, a Bacterium with Potential Bioremediation Abilities, Isolated from Petroleum Sludge
por: Al Hefeiti, Manal A., et al.
Publicado: (2018)

Correction for Al Hefeiti et al., “Draft Genome Sequence of Bacillus cereus Strain UAEU-H3K6M1, a Bacterium with Potential Bioremediation Abilities, Isolated from Petroleum Sludge”
por: Al Hefeiti, Manal A., et al.
Publicado: (2018)

Role of SARS-CoV-2 and ACE2 variations in COVID-19
por: Antony, Priya, et al.
Publicado: (2021)

From sequence analysis of DPP-4 to molecular docking based searching of its inhibitors
por: Alsamghan, Awad Saeed, et al.
Publicado: (2020)

Dynamics of the interaction between the receptor-binding domain of SARS-CoV-2 Omicron (B.1.1.529) variant and human angiotensin-converting enzyme 2
por: Antony, Priya, et al.
Publicado: (2022)

Novel Plant-Protein (Quinoa) Derived Bioactive Peptides with Potential Anti-Hypercholesterolemic Activities: Identification, Characterization and Molecular Docking of Bioactive Peptides
por: Ajayi, Feyisola Fisayo, et al.
Publicado: (2023)

Marine Compounds with Therapeutic Potential in Gram-Negative Sepsis
por: Solov’eva, Tamara, et al.
Publicado: (2013)

Exploring the therapeutic potential of marine-derived bioactive compounds against COVID-19
por: Singh, Rachana, et al.
Publicado: (2021)

Cardiovascular protection by DPP-4 inhibitors in preclinical studies: an updated review of molecular mechanisms
por: Zakaria, Esraa M., et al.
Publicado: (2022)

Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potential
por: Mikhail, Nasser
Publicado: (2008)

Insights into the Interaction of LVV-Hemorphin-7 with Angiotensin II Type 1 Receptor
por: Ali, Amanat, et al.
Publicado: (2020)

From Marine Origin to Therapeutics: The Antitumor Potential of Marine Algae-Derived Compounds
por: Alves, Celso, et al.
Publicado: (2018)

Establishment of a selective evaluation method for DPP4 inhibitors based on recombinant human DPP8 and DPP9 proteins
por: Liu, Jinglong, et al.
Publicado: (2014)

Clinical Use of DPP-4 Inhibitors
por: Gallwitz, Baptist
Publicado: (2019)

Renoprotective Effects of DPP-4 Inhibitors
por: Kawanami, Daiji, et al.
Publicado: (2021)

The potential effects of DPP‐4 inhibitors on cardiovascular system in COVID‐19 patients
por: Du, Hengzhi, et al.
Publicado: (2020)

New quinoxaline compounds as DPP-4 inhibitors and hypoglycemics: design, synthesis, computational and bio-distribution studies
por: Syam, Yasmin M., et al.
Publicado: (2021)

Relook at DPP-4 inhibitors in the era of SGLT-2 inhibitors
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence
por: Zhang, Tianli, et al.
Publicado: (2021)

Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance
por: Sharma, Ashwani, et al.
Publicado: (2022)

Potential repurposing of DPP4 inhibitors for target therapy resistance in renal cell carcinoma
por: Horie, Kuniko, et al.
Publicado: (2023)

Protease Inhibitors from Marine Actinobacteria as a Potential Source for Antimalarial Compound
por: Karthik, L., et al.
Publicado: (2014)

Potential inhibitors for SARS-CoV-2 Mpro from marine compounds
por: Tam, Nguyen Minh, et al.
Publicado: (2021)

Impacts of the DPP-4 Inhibitor Saxagliptin and SGLT-2 Inhibitor Dapagliflozin on the Gonads of Diabetic Mice
por: Alshamrani, Ali A., et al.
Publicado: (2023)

Interaction of hemorphins with ACE homologs
por: Jobe, Amie, et al.
Publicado: (2023)

Acute myocardial infarction associated to DPP-4 inhibitors
por: Nunes, J P L, et al.
Publicado: (2014)

Use of DPP-4 inhibitors in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Molecular docking and pharmacophore studies of heterocyclic compounds as Heat shock protein 90 (Hsp90) Inhibitors
por: Baby, Suby T, et al.
Publicado: (2016)

Therapeutic stimulation of GLP-1 and GIP protein with DPP-4 inhibitors for type-2 diabetes treatment
por: Sharma, Alok, et al.
Publicado: (2015)

Marine Natural Compounds with Biomedical Potential
por: Leychenko, Elena
Publicado: (2022)

COVID-19 and diabetes: Is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications
por: Barchetta, Ilaria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vlf76ajgh2qltgr60hbo3bhapq